The European Health Catapult Program for Medtech, Biotech and Digital Health Startups
Through dedicated sessions, a group of international top-level investors, key healthcare leaders and industry stakeholders work closely together challenging 40+ ambitious startups to optimize their business plan and strengthen their pitch deck.
Read more ...
Better@Home Successfully Completes First Financing Round
The Berlin-based start-up Better@Home, founded in the summer of 2018 and operating in Germany, successfully completed its first financing round in December with more than 1 million euros. The investors are CompuGroup Medical Research GmbH, an undisclosed healthcare consultant, and B.I.F. GmbH, the holding company of Hamburg-based business angel Wolfgang Biedermann.
Read more ...
Flagship Axe the Fax Trust Rolls out Hybrid Solution to Tackle Last Fax Machines
Leeds Teaching Hospitals NHS Trust (LTHT), the organisation at the forefront of the national Axe the Fax campaign, is implementing an electronic fax solution to tackle its last remaining machines. In September, the Trust set out a highly ambitious goal to remove the majority of its 350 fax machines by the beginning of 2019 in order to streamline workflows and productivity, improve security and improve the timeliness of patient care.
Read more ...
Enovacom and Stalis Join Forces to Unlock the Value of UK Health Data
Enovacom and Stalis have joined forces to help UK health and care providers breakdown the technical barriers of extracting and sharing patient data to create integrated care records that support better care outcomes and improvements in the patient experience.
Read more ...
Highland Marketing Advisory Board Responds to the NHS Long Term Plan
The first meeting of Highland Marketing's newly expanded advisory board discussed the NHS Long Term Plan and what will be needed to make it a success. Structural change, leadership, investment, spending on the right systems at the right level, and empowerment emerged as key themes.
Read more ...
Merck Granted U.S. Patent for Novel Combination of Artificial Intelligence and Blockchain Technology
Merck, a leading science and technology company, today announced that it has been granted Patent No. US 10,193,695 by the United States Patent and Trademark Office (USPTO). The patent relates to the formation of 'crypto-objects', a novel security procedure linking Artificial Intelligence (AI) and blockchain technology.
Read more ...
Clinical Study Confirms Effectiveness of CardioSecur® in Pre-Clinical Deployment in Ambulances
The study "CardioSecur® in the preclinical setting - When time does matter" of the University of Heidelberg confirms the advantages of the mobile ECG in acute cases. This was demonstrated by applying CardioSecur during a period of more than 7 months in ambulances in the area of Heidelberg, Germany.
Read more ...
Through dedicated sessions, a group of international top-level investors, key healthcare leaders and industry stakeholders work closely together challenging 40+ ambitious startups to optimize their business plan and strengthen their pitch deck. 
The Berlin-based start-up Better@Home, founded in the summer of 2018 and operating in Germany, successfully completed its first financing round in December with more than 1 million euros. The investors are CompuGroup Medical Research GmbH, an undisclosed healthcare consultant, and B.I.F. GmbH, the holding company of Hamburg-based business angel Wolfgang Biedermann. 
The first meeting of Highland Marketing's newly expanded advisory board discussed the NHS Long Term Plan and what will be needed to make it a success. Structural change, leadership, investment, spending on the right systems at the right level, and empowerment emerged as key themes. 
Merck, a leading science and technology company, today announced that it has been granted Patent No. US 10,193,695 by the United States Patent and Trademark Office (USPTO). The patent relates to the formation of 'crypto-objects', a novel security procedure linking Artificial Intelligence (AI) and blockchain technology. 
The study "CardioSecur® in the preclinical setting - When time does matter" of the University of Heidelberg confirms the advantages of the mobile ECG in acute cases. This was demonstrated by applying CardioSecur during a period of more than 7 months in ambulances in the area of Heidelberg, Germany.